Having COVID-19 pneumonia vs. non-COVID-19 pneumonia while receiving extracorporeal membrane oxygenation negatively impacted ...

VOV.VN - Nearly 200 domestic and international experts are sharing experience in deploying the extracorporeal membrane ...

The global cardiogenic shock market is projected to grow from $3.57 billion in 2024 to $5.2 billion by 2030, driven by the rising prevalence of cardiovascular diseases (CVDs) and advancements in ...

Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...

Both patients view every day as a gift after overcoming incredible odds. A recent NIH study showed that the survival rate of adult ECMO patients is about 60%.

for the treatment of COVID-19 in hospitalized adults when initiated within 48 hours of receiving invasive mechanical ventilation (IMV) or extracorporeal membrane oxygenation (ECMO). The emergency use ...